FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ResMed's Free Cash Flow for the
three
months ended in Dec. 2023 was $248 Mil. ResMed's Revenue for the
three
months ended in Dec. 2023 was $1,163 Mil. Therefore, ResMed's FCF Margin % for the quarter that ended in Dec. 2023 was 21.35%.
The historical rank and industry rank for ResMed's FCF Margin % or its related term are showing as below:
RMD'
s FCF Margin % Range Over the Past 10 Years
Min: 5.45 Med: 18.54 Max: 26.11
Current: 20.95
During the past 13 years, the highest FCF Margin % of ResMed was 26.11%. The lowest was 5.45%. And the median was 18.54%.
RMD's FCF Margin % is ranked better than 93.08% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: -7.14
vs RMD: 20.95
ResMed FCF Margin % Historical Data
The historical data trend for ResMed's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's FCF Margin % distribution charts can be found below:
* The bar in red indicates where ResMed's FCF Margin % falls into.
ResMed FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
ResMed's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed FCF Margin % Related Terms
Thank you for viewing the detailed overview of ResMed's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RMD has been successfully added to your 